![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1675337
AI ´ëÀÀ X¼± À̹Ì¡ ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç°º°, ¹èÆ÷ ¸ðµåº°, ¿öÅ©Ç÷ο캰, ¾ÖÇø®ÄÉÀ̼Ǻ°, Áö¿ªº°(2025-2033³â)AI-Enabled X-Ray Imaging Solutions Market by Product, Mode of Deployment, Workflow, Application, and Region 2025-2033 |
¼¼°èÀÇ AI ´ëÀÀ X¼± À̹Ì¡ ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 2¾ï 4,200¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 9¾ï 4,960¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³â¿¡ 15.58%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î »ê¾÷ÀÇ ²ÙÁØÇÑ È®´ë, ´ëÆøÀûÀÎ ±â¼ú ¹ßÀü, ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿ÀÌ ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.
ÀΰøÁö´É(AI) Áö¿ø ¿¢½º·¹ÀÌ À̹Ì¡ ¼Ö·ç¼ÇÀº ¿µ»óÀÇÇаú Àü¹®Àǰ¡ ´Ù¾çÇÑ Àå±â¿Í ±× »óÅÂÀÇ º¹ÀâÇÑ À̹ÌÁö¸¦ Æò°¡ÇÏ°í ½Å¼ÓÇϰí Á¤È®ÇÏ°Ô °Ë»çÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â ÀÇ·á Áø´Ü ½´Æ®ÀÔ´Ï´Ù. ÄÄÇ»ÅÍÈµÈ ¾Ë°í¸®ÁòÀ» »ç¿ëÇÏ¿© µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ°í ¿¹Ãø ºÐ¼® ¹× À§Çè Æò°¡¸¦ ¼öÇàÇÏ´Â ´Ù¾çÇÑ ¼ÒÇÁÆ®¿þ¾î ¹× Çϵå¿þ¾î ¼Ö·ç¼ÇÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ AI Áö¿ø ¿¢½º·¹ÀÌ À̹Ì¡ ¼Ö·ç¼ÇÀº ÁýÁßÀûÀÎ ¿µ»ó ¼öÁý, ºÐ·ù, Ä¡·á ¹æÄ§ °áÁ¤ Áö¿ø, ¿µ»ó ºÐ¼®, º¸°í ¹× Ä¿¹Â´ÏÄÉÀ̼Ç, Áø´ÜÀ» Ç¥ÁØ ¼ºñ½º·Î Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â Àΰ£ÀÇ Àü¹®¼º ¿ä±¸ »çÇ×À» ÁÙÀ̰í, Á¤º¸ Áß½ÉÀÇ Á¢±Ù ¹æ½ÄÀ» °¡´ÉÇÏ°Ô Çϸç, À̹ÌÁö ǰÁúÀ» Çâ»ó½Ã۰í, ¹æ»ç¼± ÇÇÆøÀ» ÁÙÀ̸ç, Àǻ簡 ´õ ³ªÀº ÀÓ»óÀû ÆÇ´ÜÀ» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ±× °á°ú, AI Áö¿ø X-·¹ÀÌ À̹Ì¡ ¼Ö·ç¼ÇÀº ÀÏ¹Ý ¹× Àü¹® ¹æ»ç¼± ºÐ¾ß¿¡¼ ³Î¸® »ç¿ëµÇ¾î ȯÀÚÀÇ ÀÌ»óÀ» ±¤¹üÀ§ÇÏ°Ô ¹àÇô³»°í ´õ ³ªÀº Ä¡·á ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.
ÇコÄÉ¾î »ê¾÷¿¡¼ ÀΰøÁö´É(AI) ¹× ±âŸ °è»ê ¾Ë°í¸®ÁòÀÇ ±¤¹üÀ§ÇÑ ÅëÇÕÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿ä¼Ò Áß ÇϳªÀÔ´Ï´Ù. ÀÌ¿Í ÇÔ²² ´Ù¾çÇÑ ¸¸¼ºÁúȯ ¹× ½ÉÇ÷°ü Áúȯ(CVD)À» °¨ÁöÇϱâ À§ÇÑ °í±Þ ¿µ»ó Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ °³ÀεéÀÇ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT), ÀÚ±â°ø¸í¿µ»ó(MR), À¯¹æÃÔ¿µ, ¸ÖƼ¸ð´Þ¸®Æ¼ À̹Ì¡ ½Ã½ºÅÛ, ÃÊÀ½ÆÄ µî ´Ù¾çÇÑ ¿µ»ó ¾ç»óÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀÌ Àü ¼¼°è¿¡¼ Á¦Ç° ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ð¹ÙÀÏ ¿¢½º·¹ÀÌ ¿ëµµÀÇ ÃâÇö°ú ¼ÒÇÁÆ®¿þ¾î ±â´É ¹× ÀåºñÀÇ °³¼± Ãø¸é¿¡¼ »ó´çÇÑ ±â¼ú ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ µö·¯´×, ¸Ó½Å·¯´×(ML), ·Îº¿ °øÇÐÀÇ ´ë±Ô¸ð ÅëÇÕÀ¸·Î ÀÎÇØ Á¤È®µµ ÃÖÀûÈ ¹× °í±Þ ÀÚµ¿È¸¦ ÅëÇØ »ý»ê¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹Í ±â°£ Áß Áø´Ü ¹× ¿ø°ÝÀǷḦ ÅëÇØ ¿µ»ó¿¡ ´ëÇÑ ¿ø°Ý ¾×¼¼½º¸¦ ¾ò±â À§ÇØ AI Áö¿ø ¿¢½º·¹ÀÌÀÇ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °ÍÀº ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÕ´Ï´Ù. À̿ʹ º°µµ·Î, ½Å·Ú¼º, ¾ÈÁ¤¼º, Áï°¢ÀûÀ¸·Î ÀçÇö °¡´ÉÇÑ Áúº´ Á¤º¸ µî ¿©·¯ Á¦Ç°ÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °í±Þ ÀÚµ¿È¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ÃÖ±Ù ¿¬±¸°³¹ß(R&D) Ȱµ¿Àº ÇコÄÉ¾î »ê¾÷ÀÇ ´ëÆøÀûÀÎ È®Àå°ú ÇÔ²² ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
The global AI-enabled X-ray imaging solutions market size reached USD 242.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 949.6 Million by 2033, exhibiting a growth rate (CAGR) of 15.58% during 2025-2033. The steady expansion in the healthcare industry, significant technological advancements, and extensive research and development (R&D) activities represent some of the key factors driving the market.
Artificial intelligence (AI)-enabled X-ray imaging solutions represent a suit of medical diagnostics that enables radiologists to evaluate and examine intricate images of diverse organs and their conditions at improved speed and accuracy. They employ various software and hardware solutions that use computerized algorithms to analyze data and perform predictive analysis and risk assessments. Moreover, AI-enabled X-ray imaging solutions offer intensive image acquisition, triage, treatment decision support, image analysis, reporting and communication, and diagnosis as standard services. These facilities reduce the requirement of human specialties, allow an information-driven approach, enhance the picture quality, reduce radiation exposure, and enable practitioners to make better clinical decisions. As a result, AI-enabled X-ray imaging solutions are widely used in general and specialty radiology for the extensive clarification of abnormalities amongst patients and provide better treatment solutions.
The widespread integration of artificial intelligence (AI) and other computational algorithms in the healthcare industry represent one of the key factors driving the market growth. In line with this, the increasing need for advanced imaging and diagnostic solutions to detect various chronic and cardiovascular disorders (CVDs) amongst individuals is acting as another growth-inducing factor. Additionally, the extensive utilization of multiple imaging modalities, including computer tomography (CT), magnetic resonance (MR), mammography, multimodality imaging systems, and ultrasound, has further facilitated product demand across the globe, which is contributing to the market growth. Moreover, the advent of mobile X-ray applications and significant technological advancements in terms of improvements in software capabilities and facilities are supporting the market growth. This can be further attributed to the large-scale integration of deep learning, machine learning (ML) and robotics, which help increase productivity by optimizing precision and high-grade automation. Furthermore, the escalating usage of AI-enabled X-rays during the COVID-19 pandemic to diagnose and gain remote access to images via telehealth is favoring the market growth. Apart from this, the rising awareness regarding multiple product benefits, such as reliability, stability and instant reproducible disease information and recent research and development (R&D) activities to enable high-grade automation, along with significant expansion in the healthcare industry are positively impacting the market growth.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.